Pure Red Cell Aplasia Associated With Thymic Tumors, a Nationwide Retrospective Study

Area of Science:

• Hematology
• Oncology
• Immunology

Background:

• Pure red cell aplasia (PRCA) is the most common autoimmune cytopenia associated with thymic tumors (TTs).
• The association between PRCA and TTs presents a significant clinical challenge due to potential complications and treatment complexities.

Purpose of the Study:

• To investigate the clinical characteristics, treatment outcomes, and prognostic factors in patients with concurrent PRCA and TTs.
• To evaluate the efficacy and safety of various treatment modalities for PRCA in the context of TTs.

Main Methods:

• A nationwide retrospective study involving 41 patients diagnosed with both PRCA and TTs.
• Analysis of patient demographics, PRCA and TT diagnosis timing, treatment responses (corticosteroids, cyclosporine A, sirolimus, thymectomy), relapse rates, and survival outcomes.

Main Results:

• PRCA diagnosis occurred before, simultaneously with, or after TT diagnosis in 8%, 46%, and 46% of patients, respectively.
• Immunosuppressive therapies showed high initial response rates (corticosteroids 77%, cyclosporine A 71%), but frequent relapses occurred (54% experienced multiple relapses).
• Severe infectious events were frequent (44%), and overall mortality was 12%, with TT relapse being a cause of death in three patients.

Conclusions:

• The association of TT and PRCA is characterized by a severe clinical phenotype with frequent relapses and high incidence of infections.
• While immunosuppressive therapy can induce PRCA response, thymoma relapse and infections contribute significantly to morbidity and mortality.
• Thymectomy alone offered a sustainable PRCA response in one case, suggesting potential benefit in select patients.